These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23946789)

  • 1. Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis.
    Liu Z; Ling Q; Wang J; Xie H; Xu X; Zheng S
    Oncol Lett; 2013 Jul; 6(1):125-129. PubMed ID: 23946789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
    Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
    World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients.
    Shaker MK; Abdel Fattah HI; Sabbour GS; Montasser IF; Abdelhakam SM; El Hadidy E; Yousry R; El Dorry AK
    World J Hepatol; 2017 Mar; 9(9):469-476. PubMed ID: 28396717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Limitations of Tissue Annexin A2 Level as a Predictor of Postoperative Overall Survival in Patients with Hepatocellular Carcinoma.
    Huang SW; Chen YC; Lin YH; Yeh CT
    J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of annexin II as a potential serum marker for hepatocellular carcinoma using a developed sandwich ELISA method.
    Ji NY; Park MY; Kang YH; Lee CI; Kim DG; Yeom YI; Jang YJ; Myung PK; Kim JW; Lee HG; Kim JW; Lee K; Song EY
    Int J Mol Med; 2009 Dec; 24(6):765-71. PubMed ID: 19885616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
    El-Abd N; Fawzy A; Elbaz T; Hamdy S
    Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
    Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
    Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.
    Ma LN; Liu XY; Lu ZH; Wu LG; Tang YY; Luo X; Hu YC; Yan TT; Wang Q; Ding XC; Xie Y
    Oncol Lett; 2017 May; 13(5):3457-3464. PubMed ID: 28521452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
    Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
    Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
    Sun Y; Gao G; Cai J; Wang Y; Qu X; He L; Liu F; Zhang Y; Lin K; Ma S; Yang X; Qian X; Zhao X
    Carcinogenesis; 2013 Mar; 34(3):595-604. PubMed ID: 23188673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B.
    Kolgelier S; Demir NA; Inkaya AC; Sumer S; Ozcimen S; Demir LS; Pehlivan FS; Arslan M; Arpaci A
    Hepat Mon; 2015 Oct; 15(10):e30655. PubMed ID: 26587036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis.
    Tang L; Liu JX; Zhang ZJ; Xu CZ; Zhang XN; Huang WR; Zhou DH; Wang RR; Chen XD; Xiao MB; Qu LS; Lu CH
    Pathol Res Pract; 2019 Jun; 215(6):152386. PubMed ID: 30935762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA.
    Zhu C; Song H; Shen B; Wu L; Liu F; Liu X
    Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Annexin A2 gene transcription is a promising molecular target for hepatoma cell proliferation and metastasis.
    Dong Z; Yao M; Zhang H; Wang L; Huang H; Yan M; Wu W; Yao D
    Oncol Lett; 2014 Jan; 7(1):28-34. PubMed ID: 24348815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
    Choi CH; Chung JY; Chung EJ; Sears JD; Lee JW; Bae DS; Hewitt SM
    BMC Cancer; 2016 Jul; 16():448. PubMed ID: 27402115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium channel α2δ1 subunit as a novel biomarker for diagnosis of hepatocellular carcinoma.
    Amhimmid Badr S; Waheeb Fahmi M; Mahmoud Nomir M; Mohammad El-Shishtawy M
    Cancer Biol Med; 2018 Feb; 15(1):52-60. PubMed ID: 29545968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
    Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.